{
    "title": "Kodiak's eye drug fails to match Eylea in trial, shares sink",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10542717/Kodiak-Sciences-fails-meet-mid-late-stage-study-goal-eye-drug.html",
    "date": "2022-02-23",
    "keywords": [
        "drug",
        "study",
        "trial",
        "eylea",
        "eye",
        "regeneron",
        "vision",
        "year",
        "leo",
        "failure",
        "dosing",
        "safety",
        "inflammation",
        "wednesday",
        "midtolatestage",
        "degeneration",
        "disorder",
        "management",
        "protocol",
        "company",
        "executive",
        "victor",
        "perlroth",
        "call",
        "month",
        "interval",
        "none",
        "analyst",
        "note",
        "overhang",
        "stock",
        "treatment",
        "kodiak",
        "low",
        "morning",
        "trade",
        "reporting",
        "editing",
        "krishna",
        "chandra",
        "eluri",
        "sriraj",
        "kalluvila",
        "anil",
        "dsilva"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}